01 PEPITIDE PLATFORM

PepiX: generate stable and effective peptides using our AI-Powered Peptide Discovery Platform

02
AI-powered peptide design

Stable and effective peptides for any target with AI-driven discovery

AI models design peptides tailored to binding sites for any druggable target

3 AI modules power peptide design and screening
PepiX's AI models work in tandem to generate the peptide backbone, complete the sequence, and perform
High quality, proprietary data improves model accuracy
1M data points curated through proprietary processes
PepiX enables de novo design for any target, with or without a known protein-protein interaction
High affinity peptide (22 nM) generated in a matter of months through rational design
03
Format optimization

Enhancing peptide efficacy with custom design and novel formats

A proprietary library of 1,000+ NCAAs helps fine-tune stability, permeability, and enable cyclic
formats

A library of 1000+ Non-Canonical Amino Acids (NCAAs) enables tailored design for every project.
AI models incorporate each NCAA with custom parameters for rational peptide design
Our AI Design is a versatile tool for any sequence format.
Our models can be successfully adapted for mini-protein or RNA design
04
High throughput screening capabilities

Hit to Lead Optimization with Fit For Purpose High Throughput Screening

In silico AI predictions and high-throughput in vitro screening are used to identify hits with optimal safety and efficacy

mRNA display enables high throughput screening in linear or cyclical formats.
Libraries up to 10^14 with a well established protocol enabling hit to lead optimization in 6 weeks
One-Bead-One-Compound (OBOC) screening leverages NCAAs to fine tune binding and stablity.
Streamlined workflow with AI design with >90% library accuracy

Your next success starts here

Harness the power of AI & Automation to discover new life-changing drugs, faster and more efficiently.

Search XtalPi

Templated Nucleation of Clotrimazole and Ketoprofen on Polymer Substrates
Tale of Two Polymorphs: Investigating the Structural Differences and Dynamic Relationship between Nirmatrelvir Solid Forms (Paxlovid)
Cocrystal Synthesis through Crystal Structure Prediction

XtalPi Newsletter